Kiora Pharmaceuticals (KPRX) Stock Chart & Stock Price History $3.08 -0.02 (-0.80%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Kiora Pharmaceuticals Stock Price Performance The Kiora Pharmaceuticals (KPRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 36.50%, with a year-to-date return of -6.48%. In the past month, the stock has increased 2.19%, reflecting recent market activity. As of the latest close, Kiora Pharmaceuticals traded at $3.12 with a market cap of $9.48 million and volume of 4,986 shares. Receive KPRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kiora Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.46%1 Month Performance+2.19%3 Month Performance-11.07%Year-To-Date Performance-6.48%1 Year Performance-36.50% KPRX Stock Chart for Thursday, May, 22, 2025 KPRX Chart by TradingView Kiora Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$3.13$3.12-0.48%$3.21$3.114,986 shs$9.48 million05/20/2025$3.16$3.13-0.95%$3.17$3.121,884 shs$9.53 million05/19/2025$3.23$3.16-2.17%$3.22$3.104,233 shs$9.62 million05/16/2025$3.13$3.23+3.19%$3.27$3.1013,094 shs$9.83 million05/15/2025$3.09$3.13+1.29%$3.14$2.966,889 shs$9.53 million05/14/2025$3.19$3.09-3.13%$3.16$2.8526,979 shs$9.41 million05/13/2025$3.21$3.19-0.50%$3.30$3.158,111 shs$9.71 million05/12/2025$3.25$3.21-1.35%$3.29$3.1910,269 shs$9.76 million05/09/2025$3.12$3.25+4.17%$3.25$3.017,462 shs$9.89 million05/08/2025$3.35$3.12-6.87%$3.41$3.1034,628 shs$9.50 million Get the Latest News and Ratings for KPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kiora Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$3.30$3.35+1.67%$3.48$3.2610,258 shs$10.20 million05/06/2025$3.30$3.30-0.15%$3.38$3.294,453 shs$10.03 million05/05/2025$3.32$3.30-0.60%$3.44$3.268,658 shs$9.90 million05/02/2025$3.29$3.32+1.07%$3.38$3.187,222 shs$9.96 million05/01/2025$3.22$3.29+2.02%$3.39$3.2313,516 shs$9.86 million04/30/2025$3.22$3.22+0.03%$3.33$3.048,301 shs$9.66 million04/29/2025$3.30$3.22-2.45%$3.52$3.2011,223 shs$9.66 million04/28/2025$3.20$3.30+3.12%$3.45$3.2260,790 shs$9.90 million04/25/2025$3.20$3.20$3.23$3.179,261 shs$9.60 million04/24/2025$3.15$3.20+1.62%$3.29$3.065,571 shs$9.60 million04/23/2025$3.02$3.15+4.27%$3.25$3.107,884 shs$9.45 million04/22/2025$2.87$3.02+5.23%$3.10$2.943,296 shs$9.06 million04/21/2025$2.79$2.87+2.87%$2.88$2.794,166 shs$8.61 million Related Companies Pluri Stock Chart Oncolytics Biotech Stock Chart Eliem Therapeutics Stock Chart Reviva Pharmaceuticals Stock Chart Acrivon Therapeutics Stock Chart Aligos Therapeutics Stock Chart Estrella Immunopharma Stock Chart Alterity Therapeutics Stock Chart FibroBiologics Stock Chart OS Therapies Stock Chart Receive KPRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kiora Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KPRX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiora Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kiora Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KPRX Stock Free KPRX Stock Alerts